QA: CAMBREX CORP in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2019_CAMBREX_CORP.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000820081')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000820081, CAMBREX CORP

  xvar xval
0 AssetsCurrent 410,092,000
1 IntangibleAssetsNetIncludingGoodwill 448,300,000
2 PropertyPlantAndEquipmentNet 360,528,000
3 remainder_Assets 4,508,000
4 LiabilitiesCurrent 104,412,000
5 LiabilitiesNoncurrent 65,795,000
6 remainder_Liabilities 399,494,000
7 CostOfGoodsAndServicesSold 335,405,000
8 SellingGeneralAndAdministrativeExpense 68,506,000
9 ResearchAndDevelopmentExpense 15,547,000
10 remainder_Expenses 27,735,000
11 remainder_Revenues 532,093,000
12 remainder_NetIncome 7,518,000
13 remainder_ComprehensiveNetIncome -17,909,000
  yvar yval
0 Assets 1,223,428,000
1 Liabilities 569,701,000
2 Expenses 447,193,000
3 Revenues 532,093,000
4 StockholdersEquity 653,727,000
5 NetIncome 92,418,000
6 ComprehensiveNetIncome 83,463,500
7 BaseVar 1,398,921,000
8 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time